Amy Hagstrom Miller on Today’s FDA Mifepristone Announcement
Today’s FDA announcement of a label change to Mifepristone is a significant advancement for women in the United States. All of us at Whole Woman’s Health are thrilled that the updated FDA labeling reflects evidence based care that is best for women. People who visit our clinics deserve options for abortion care without worrying about …